Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2019-09-13 2019-08-13
Drug Identification Number 02243333 02243333
Brand name FERRLECIT FERRLECIT
Common or Proper name Ferrlecit Ferrlecit
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients IRON IRON
Strength(s) 12.5MG 12.5MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 10
ATC code B03AC B03AC
ATC description IRON PREPARATIONS IRON PREPARATIONS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-09-30 2019-09-30
Actual start date
Estimated end date 2019-11-30 2019-11-30
Actual end date 2019-09-12
Shortage status Avoided shortage Anticipated shortage
Company comments The anticipated availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Delay in testing
Health Canada comments